{"title":"MID-NET<sup>®</sup>适当的药物安全性评估数据:从研究肺动脉高压处方药患者肝功能下降发生率和检查生物仿制药的实际应用的研究中获得的经验教训","authors":"Maki KOMAMINE, Tomoaki HASEGAWA, Takashi ANDO, Yoshiaki UYAMA","doi":"10.3820/jjpe.28.e1","DOIUrl":null,"url":null,"abstract":"目的： MID-NET®はこれまでにさまざまな薬剤疫学的な解析を通じて市販後の医薬品安全性評価に貢献している．適切な活用を促進する一助とするため，MID-NET®の特徴把握のための二つの調査を実施した．本稿では，これらの調査結果を述べ，今後の調査における留意点等を考察する．","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Characterization of MID-NET<sup>®</sup> Data for Appropriate Drug Safety Assessment： Lessons Learned from Studies Investigating Incidence of Decreased Liver Function in Patients Prescribed Drugs for Pulmonary Arterial Hypertension and Examining Real World Utilization of Biosimilars\",\"authors\":\"Maki KOMAMINE, Tomoaki HASEGAWA, Takashi ANDO, Yoshiaki UYAMA\",\"doi\":\"10.3820/jjpe.28.e1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"目的： MID-NET®はこれまでにさまざまな薬剤疫学的な解析を通じて市販後の医薬品安全性評価に貢献している．適切な活用を促進する一助とするため，MID-NET®の特徴把握のための二つの調査を実施した．本稿では，これらの調査結果を述べ，今後の調査における留意点等を考察する．\",\"PeriodicalId\":14576,\"journal\":{\"name\":\"Japanese Journal of Pharmacoepidemiology\\\\/yakuzai Ekigaku\",\"volume\":\"12 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese Journal of Pharmacoepidemiology\\\\/yakuzai Ekigaku\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3820/jjpe.28.e1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3820/jjpe.28.e1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Characterization of MID-NET<sup>®</sup> Data for Appropriate Drug Safety Assessment： Lessons Learned from Studies Investigating Incidence of Decreased Liver Function in Patients Prescribed Drugs for Pulmonary Arterial Hypertension and Examining Real World Utilization of Biosimilars
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
